{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:26:53Z","timestamp":1792992413791,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360543"],"award-info":[{"award-number":["82360543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232ACB216011"],"award-info":[{"award-number":["20232ACB216011"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232ACB206043"],"award-info":[{"award-number":["20232ACB206043"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major science and technology R&D projects of Jiangxi Province","award":["20213AAG01013"],"award-info":[{"award-number":["20213AAG01013"]}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06248-1","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:45:04Z","timestamp":1740159904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10"],"prefix":"10.1186","volume":"23","author":[{"given":"Weilai","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"1","key":"6248_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, et al. Osteosarcoma. Nat Rev Dis Primers. 2022;8(1):77.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"6248_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/cancers13030388","volume":"13","author":"MJ Brookes","year":"2021","unstructured":"Brookes MJ, Chan CD, Baljer B, Wimalagunaratna S, Crowley TP, Ragbir M, et al. Surgical advances in osteosarcoma. Cancers (Basel). 2021;13(3):388.","journal-title":"Cancers (Basel)."},{"issue":"11","key":"6248_CR3","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/cncr.34163","volume":"128","author":"S Cole","year":"2022","unstructured":"Cole S, Gianferante DM, Zhu B, Mirabello L. Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017. Cancer. 2022;128(11):2107\u201318.","journal-title":"Cancer"},{"issue":"10","key":"6248_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","volume":"18","author":"J Gill","year":"2021","unstructured":"Gill J, Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol. 2021;18(10):609\u201324.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6248_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","volume":"11","author":"H Tian","year":"2023","unstructured":"Tian H, Cao J, Li B, Nice EC, Mao H, Zhang Y, et al. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res. 2023;11(1):11.","journal-title":"Bone Res"},{"issue":"Pt 18","key":"6248_CR6","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1242\/jcs.069963","volume":"123","author":"M Archinti","year":"2010","unstructured":"Archinti M, Lacasa C, Teixido-Travesa N, Luders J. SPICE\u2013a previously uncharacterized protein required for centriole duplication and mitotic chromosome congression. J Cell Sci. 2010;123(Pt 18):3039\u201346.","journal-title":"J Cell Sci"},{"issue":"14","key":"6248_CR7","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.cub.2013.06.002","volume":"23","author":"D Comartin","year":"2013","unstructured":"Comartin D, Gupta GD, Fussner E, Coyaud E, Hasegan M, Archinti M, et al. CEP120 and SPICE1 cooperate with CPAP in centriole elongation. Curr Biol. 2013;23(14):1360\u20136.","journal-title":"Curr Biol"},{"issue":"3","key":"6248_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1091\/mbc.E18-08-0495","volume":"30","author":"J Deretic","year":"2019","unstructured":"Deretic J, Kerr A, Welburn JPI. A rapid computational approach identifies SPICE1 as an Aurora kinase substrate. Mol Biol Cell. 2019;30(3):312\u201323.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"6248_CR9","volume":"1878","author":"Z Bai","year":"2023","unstructured":"Bai Z, Zhou Y, Peng Y, Ye X, Ma L. Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochim Biophys Acta. 2023;1878(5): 188965.","journal-title":"Biochim Biophys Acta"},{"issue":"7976","key":"6248_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620(7976):1080\u20138.","journal-title":"Nature"},{"issue":"7689","key":"6248_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553(7689):467\u201372.","journal-title":"Nature"},{"issue":"1","key":"6248_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41389-023-00460-8","volume":"12","author":"D Vanauberg","year":"2023","unstructured":"Vanauberg D, Schulz C, Lefebvre T. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies. Oncogenesis. 2023;12(1):16.","journal-title":"Oncogenesis"},{"issue":"5","key":"6248_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3892\/ol.2012.862","volume":"4","author":"ZL Liu","year":"2012","unstructured":"Liu ZL, Wang G, Peng AF, Luo QF, Zhou Y, Huang SH. Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis. Oncol Lett. 2012;4(5):878\u201382.","journal-title":"Oncol Lett"},{"issue":"1","key":"6248_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3892\/or.2013.2825","volume":"31","author":"XH Long","year":"2014","unstructured":"Long XH, Zhang GM, Peng AF, Luo QF, Zhang L, Wen HC, et al. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K\/AKT-FASN axis in vitro. Oncol Rep. 2014;31(1):328\u201334.","journal-title":"Oncol Rep"},{"issue":"4","key":"6248_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-019-1532-2","volume":"10","author":"T Sun","year":"2019","unstructured":"Sun T, Zhong X, Song H, Liu J, Li J, Leung F, et al. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma. Cell Death Dis. 2019;10(4):298.","journal-title":"Cell Death Dis"},{"issue":"1","key":"6248_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"SM Lange","year":"2022","unstructured":"Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol Cell. 2022;82(1):15\u201329.","journal-title":"Mol Cell"},{"issue":"D1","key":"6248_CR17","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, He M, Kong X, Jiang P, Liu X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50(D1):D719\u201328.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6248_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-022-01567-z","volume":"21","author":"R Yang","year":"2022","unstructured":"Yang R, Chen H, Xing L, Wang B, Hu M, Ou X, et al. Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10. Mol Cancer. 2022;21(1):88.","journal-title":"Mol Cancer"},{"issue":"6","key":"6248_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.molcel.2019.12.024","volume":"77","author":"C Meyer","year":"2020","unstructured":"Meyer C, Garzia A, Morozov P, Molina H, Tuschl T. The G3BP1-family-USP10 deubiquitinase complex rescues ubiquitinated 40S subunits of ribosomes stalled in translation from lysosomal degradation. Mol Cell. 2020;77(6):1193-205.e5.","journal-title":"Mol Cell"},{"key":"6248_CR20","doi-asserted-by":"crossref","unstructured":"Wang C, Tan X, Tang D, Gou Y, Han C, Ning W, et al. GPS-Uber: a hybrid-learning framework for prediction of general and E3-specific lysine ubiquitination sites. Briefings Bioinformatics. 2022;23(2).","DOI":"10.1093\/bib\/bbab574"},{"key":"6248_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105684","volume":"169","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu R, Wang W, Wang C, Zhang N, Shao X, et al. Advances in targeted therapy for osteosarcoma based on molecular classification. Pharmacol Res. 2021;169: 105684.","journal-title":"Pharmacol Res"},{"key":"6248_CR22","doi-asserted-by":"crossref","unstructured":"Hu Z, Wen S, Huo Z, Wang Q, Zhao J, Wang Z, et al. Current status and prospects of targeted therapy for osteosarcoma. Cells. 2022;11(21).","DOI":"10.3390\/cells11213507"},{"key":"6248_CR23","doi-asserted-by":"crossref","unstructured":"Hattinger CM, Salaroglio IC, Fantoni L, Godel M, Casotti C, Kopecka J, et al. Strategies to overcome resistance to immune-based therapies in osteosarcoma. Int J Mol Sci. 2023;24(1).","DOI":"10.3390\/ijms24010799"},{"issue":"10","key":"6248_CR24","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s00432-020-03308-5","volume":"146","author":"L Li","year":"2020","unstructured":"Li L, Pan Y, Mo X, Wei T, Song J, Luo M, et al. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis. J Cancer Res Clin Oncol. 2020;146(10):2519\u201334.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"6248_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer. 2021;21(12):753\u201366.","journal-title":"Nat Rev Cancer"},{"issue":"7744","key":"6248_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019;566(7744):403\u20136.","journal-title":"Nature"},{"issue":"7772","key":"6248_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-019-1511-x","volume":"573","author":"J Niu","year":"2019","unstructured":"Niu J, Sun Y, Chen B, Zheng B, Jarugumilli GK, Walker SR, et al. Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation. Nature. 2019;573(7772):139\u201343.","journal-title":"Nature"},{"issue":"1","key":"6248_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan SK, Hougen HY, Merchan JR, Gonzalgo ML, Welford SM. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat Rev Urol. 2023;20(1):48\u201360.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"6248_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11684-021-0830-0","volume":"15","author":"J Zhang","year":"2021","unstructured":"Zhang J, Song Y, Shi Q, Fu L. Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis. Front Med. 2021;15(5):649\u201356.","journal-title":"Front Med"},{"issue":"6","key":"6248_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100479","volume":"4","author":"B Paul","year":"2022","unstructured":"Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Reports Innov Hepatol. 2022;4(6): 100479.","journal-title":"JHEP Reports Innov Hepatol"},{"issue":"1","key":"6248_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41392-022-01099-4","volume":"7","author":"D Cao","year":"2022","unstructured":"Cao D, Yang J, Deng Y, Su M, Wang Y, Feng X, et al. Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma. Signal Transduct Target Ther. 2022;7(1):273.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6248_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-021-00493-8","volume":"6","author":"J Deng","year":"2021","unstructured":"Deng J, Peng M, Zhou S, Xiao D, Hu X, Xu S, et al. Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c\/FASN axis. Signal Transduct Target Ther. 2021;6(1):98.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"6248_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro GB, Ali A, Luengo A, Kodack DP, Deik A, Abbott KL, et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat Cancer. 2021;2(4):414\u201328.","journal-title":"Nat Cancer"},{"issue":"4","key":"6248_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/hep.32359","volume":"76","author":"H Wang","year":"2022","unstructured":"Wang H, Zhou Y, Xu H, Wang X, Zhang Y, Shang R, et al. Therapeutic efficacy of FASN inhibition in preclinical models of HCC. Hepatology (Baltimore, MD). 2022;76(4):951\u201366.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"6248_CR35","doi-asserted-by":"crossref","unstructured":"Fan H, Huang W, Guo Y, Ma X, Yang J. \u03b1-Linolenic acid suppresses proliferation and invasion in osteosarcoma cells via inhibiting fatty acid synthase. Molecules (Basel, Switzerland). 2022;27(9).","DOI":"10.3390\/molecules27092741"},{"issue":"2","key":"6248_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00041433-199904000-00008","volume":"10","author":"JD Horton","year":"1999","unstructured":"Horton JD, Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol. 1999;10(2):143\u201350.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"6248_CR37","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/bcr2777","volume":"12","author":"Q Jin","year":"2010","unstructured":"Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, et al. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res BCR. 2010;12(6):R96.","journal-title":"Breast Cancer Res BCR"},{"issue":"1","key":"6248_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y, et al. FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduct Target Ther. 2023;8(1):187.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6248_CR39","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-018-07185-y","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, Jiang S, Li M, Xiong X, Zhu M, Li D, et al. Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN. Nat Commun. 2018;9(1):4770.","journal-title":"Nat Commun"},{"issue":"12","key":"6248_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41419-020-03246-7","volume":"11","author":"U Bhattacharya","year":"2020","unstructured":"Bhattacharya U, Neizer-Ashun F, Mukherjee P, Bhattacharya R. When the chains do not break: the role of USP10 in physiology and pathology. Cell Death Dis. 2020;11(12):1033.","journal-title":"Cell Death Dis"},{"issue":"1","key":"6248_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-021-01920-y","volume":"40","author":"B Li","year":"2021","unstructured":"Li B, Qi ZP, He DL, Chen ZH, Liu JY, Wong MW, et al. NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer. J Exp Clin Cancer Res CR. 2021;40(1):126.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"1","key":"6248_CR42","first-page":"54","volume":"9","author":"ZQ Ma","year":"2022","unstructured":"Ma ZQ, Feng YT, Guo K, Liu D, Shao CJ, Pan MH, et al. Melatonin inhibits ESCC tumor growth by mitigating the HDAC7\/\u03b2-catenin\/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability. Mil Med Res. 2022;9(1):54.","journal-title":"Mil Med Res"},{"issue":"11","key":"6248_CR43","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","volume":"80","author":"H Zhu","year":"2020","unstructured":"Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP\/TAZ. Cancer Res. 2020;80(11):2204\u201316.","journal-title":"Cancer Res"},{"issue":"11","key":"6248_CR44","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s12276-022-00887-w","volume":"54","author":"A Christine","year":"2022","unstructured":"Christine A, Park MK, Song SJ, Song MS. The equilibrium of tumor suppression: DUBs as active regulators of PTEN. Exp Mol Med. 2022;54(11):1814\u201321.","journal-title":"Exp Mol Med"},{"issue":"3","key":"6248_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","volume":"140","author":"J Yuan","year":"2010","unstructured":"Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010;140(3):384\u201396.","journal-title":"Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06248-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:45:13Z","timestamp":1740159913000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06248-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6248"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06248-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out with the approval of the Ethics Committee of the First Affiliated Hospital, Jiangxi Medical College, Nanchang University (Approval Nos. (2022) CDYFYYLK (06-002) and CDYFY-IACUC-202308QR005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual person\u2019s data are given.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no potential conflicts of interest to be disclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}